NUVA Nuvasive Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NUVA

Price (delayed)

$37.795

Market cap

$1.97B

P/E Ratio

48.46

Dividend/share

N/A

EPS

$0.78

Enterprise value

$2.73B

NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. ...

Highlights
Nuvasive's net income has soared by 163% YoY
NUVA's EPS has soared by 163% YoY
NUVA's quick ratio has dropped by 70% year-on-year but it is up by 2.9% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.nuvasive.com
Peers: OFIX ATEC SYK GMED

Key stats

What are the main financial stats of NUVA
Market
Shares outstanding
52.19M
Market cap
$1.97B
Enterprise value
$2.73B
Valuations
Price to earnings (P/E)
48.46
Price to book (P/B)
2.27
Price to sales (P/S)
1.64
EV/EBIT
39.12
EV/EBITDA
12.59
EV/Sales
2.27
Earnings
Revenue
$1.2B
EBIT
$69.75M
EBITDA
$216.78M
Free cash flow
$29.89M
Per share
EPS
$0.78
Free cash flow per share
$0.57
Book value per share
$16.67
Revenue per share
$23.11
TBVPS
$26.93
Balance sheet
Total assets
$2.22B
Total liabilities
$1.36B
Debt
$1.01B
Equity
$868.89M
Working capital
$149.16M
Liquidity
Debt to equity
1.16
Current ratio
1.21
Quick ratio
0.7
Net debt/EBITDA
3.49
Margins
EBITDA margin
18%
Gross margin
72%
Net margin
3.4%
Operating margin
6.9%
Efficiency
Return on assets
1.9%
Return on equity
4.8%
Return on invested capital
4.6%
Return on capital employed
4.6%
Return on sales
5.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NUVA stock price

How has the Nuvasive stock price performed over time
Intraday
0.12%
1 week
-1.63%
1 month
-14.04%
1 year
-26.31%
YTD
-8.35%
QTD
-8.35%

Financial performance

How have Nuvasive's revenue and profit performed over time
Revenue
$1.2B
Gross profit
$865.44M
Operating income
$83.44M
Net income
$40.41M
Gross margin
72%
Net margin
3.4%
Nuvasive's net income has soared by 163% YoY
The net margin has soared by 161% YoY
The company's operating income rose by 47% YoY but it fell by 22% QoQ
NUVA's operating margin is up by 38% year-on-year but it is down by 22% since the previous quarter

Growth

What is Nuvasive's growth rate over time

Valuation

What is Nuvasive stock price valuation
P/E
48.46
P/B
2.27
P/S
1.64
EV/EBIT
39.12
EV/EBITDA
12.59
EV/Sales
2.27
NUVA's EPS has soared by 163% YoY
NUVA's price to book (P/B) is 35% less than its 5-year quarterly average of 3.5 and 24% less than its last 4 quarters average of 3.0
The equity has grown by 9% YoY and by 4.4% from the previous quarter
The price to sales (P/S) is 37% lower than the 5-year quarterly average of 2.6 and 22% lower than the last 4 quarters average of 2.1
Nuvasive's revenue has increased by 6% YoY

Efficiency

How efficient is Nuvasive business performance
The return on assets has surged by 163% year-on-year
The company's return on equity has surged by 162% YoY

Dividends

What is NUVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVA.

Financial health

How did Nuvasive financials performed over time
The total assets is 64% greater than the total liabilities
NUVA's quick ratio has dropped by 70% year-on-year but it is up by 2.9% since the previous quarter
NUVA's current ratio has dropped by 70% year-on-year
The debt is 16% more than the equity
NUVA's debt to equity is down by 9% year-on-year and by 4.1% since the previous quarter
The equity has grown by 9% YoY and by 4.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.